Advances in the treatment of acute myeloid leukemia: new drugs and new challenges
NJ Short, M Konopleva, TM Kadia, G Borthakur… - Cancer discovery, 2020 - AACR
The therapeutic armamentarium of acute myeloid leukemia (AML) has rapidly expanded in
the past few years, driven largely by translational research into its genomic landscape and …
the past few years, driven largely by translational research into its genomic landscape and …
Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges
NJ Short, M Konopleva, TM Kadia, G Borthakur… - Cancer …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title/>< jats: p> The therapeutic
armamentarium of acute myeloid leukemia (AML) has rapidly expanded in the past few …
armamentarium of acute myeloid leukemia (AML) has rapidly expanded in the past few …
Advances in the treatment of acute myeloid leukemia: New drugs and new challenges
NJ Short, M Konopleva, TM Kadia… - Cancer …, 2020 - mdanderson.elsevierpure.com
The therapeutic armamentarium of acute myeloid leukemia (AML) has rapidly expanded in
the past few years, driven largely by translational research into its genomic landscape and …
the past few years, driven largely by translational research into its genomic landscape and …
Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges.
NJ Short, M Konopleva, TM Kadia, G Borthakur… - Cancer …, 2020 - europepmc.org
The therapeutic armamentarium of acute myeloid leukemia (AML) has rapidly expanded in
the past few years, driven largely by translational research into its genomic landscape and …
the past few years, driven largely by translational research into its genomic landscape and …
Advances in the treatment of acute myeloid leukemia: New drugs and new challenges
NJ Short, M Konopleva, TM Kadia… - Cancer …, 2020 - einstein.elsevierpure.com
The therapeutic armamentarium of acute myeloid leukemia (AML) has rapidly expanded in
the past few years, driven largely by translational research into its genomic landscape and …
the past few years, driven largely by translational research into its genomic landscape and …
Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges
NJ Short, M Konopleva, TM Kadia… - Cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
The therapeutic armamentarium of acute myeloid leukemia (AML) has rapidly expanded in
the past few years, driven largely by translational research into its genomic landscape and …
the past few years, driven largely by translational research into its genomic landscape and …